0       0

AST Fellows Webinar Series


WEB140604 - Malignancies after Solid Organ Transplantation


Jun 4, 2014 2:00pm ‐ Jun 4, 2014 3:00pm


Credits: None available.

Standard: Free

Description

Exposure to immunosuppressive drugs increases the risk of malignancy in transplant recipients. The risk of malignancy varies by organ type, duration and intensity of immunosuppression, recipient age, and exposure to oncogenic viruses. Participants in this session will gain an understanding of the pathophysiology of malignancy in the transplant recipient and apply this knowledge to identify patients at high risk, develop preventative strategies to mitigate risk, ensure timely diagnosis and optimize the treatment of recipients with post transplant malignancy.

Speaker(s):

  • John S. Gill, MD, MS, University of British Columbia, St. Paul's Hospital

Speaker(s):

Credits

  • 0.00 - CE

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content